ZnT8 has been widely reported to be involved in DM [34,54,55,56]; however, its role in type II diabetes (T2D), particularly linked with a loss-of-function ZnT8 variant [55], conflicts with evidence supporting treatment of T2D by increasing ZnT8 function [54]. Here, SLC30A10 is linked to diabetes mellitus.